{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:22:23Z","timestamp":1792002143414,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Natural Science Foundation of China and the Fundamental Research Funds for the Central Universities","award":["2017KFYXJJ104"],"award-info":[{"award-number":["2017KFYXJJ104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10753-019-01143-6","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T17:05:01Z","timestamp":1591117501000},"page":"1209-1221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Neferine Inhibits Expression of Inflammatory Mediators and Matrix Degrading Enzymes in IL-1\u03b2-Treated Rat Chondrocytes via Suppressing MAPK and NF-\u03baB Signaling Pathways"],"prefix":"10.1007","volume":"43","author":[{"given":"Bowei","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekai","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6284-643X","authenticated-orcid":false,"given":"Hongbo","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"issue":"3","key":"1143_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.joca.2018.11.001","volume":"27","author":"LA Mandl","year":"2019","unstructured":"Mandl, L.A. 2019. Osteoarthritis year in review 2018: Clinical. Osteoarthritis and Cartilage 27 (3): 359\u2013364. https:\/\/doi.org\/10.1016\/j.joca.2018.11.001.","journal-title":"Osteoarthritis and Cartilage"},{"key":"1143_CR2","doi-asserted-by":"publisher","first-page":"16044","DOI":"10.1038\/boneres.2016.44","volume":"5","author":"D Chen","year":"2017","unstructured":"Chen, Di, Jie Shen, Weiwei Zhao, Tingyu Wang, Han Lin, John L. Hamilton, and Hee-Jeong Im. 2017. Osteoarthritis: Toward a comprehensive understanding of pathological mechanism. Bone Res 5: 16044. https:\/\/doi.org\/10.1038\/boneres.2016.44.","journal-title":"Bone Res"},{"issue":"2","key":"1143_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/BOR.0000000000000479","volume":"30","author":"ER Vina","year":"2018","unstructured":"Vina, E.R., and C.K. Kwoh. 2018. Epidemiology of osteoarthritis: Literature update. Current Opinion in Rheumatology 30 (2): 160\u2013167. https:\/\/doi.org\/10.1097\/BOR.0000000000000479.","journal-title":"Current Opinion in Rheumatology"},{"key":"1143_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.comppsych.2016.12.001","volume":"73","author":"S-Y Kye","year":"2017","unstructured":"Kye, Su-Yeon, and Keeho Park. 2017. Suicidal ideation and suicidal attempts among adults with chronic diseases: A cross-sectional study. Comprehensive Psychiatry 73: 160\u2013167. https:\/\/doi.org\/10.1016\/j.comppsych.2016.12.001.","journal-title":"Comprehensive Psychiatry"},{"issue":"3","key":"1143_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/ageing\/afw216","volume":"46","author":"N Veronese","year":"2017","unstructured":"Veronese, Nicola, Brendon Stubbs, Marco Solmi, Toby O. Smith, Marianna Noale, Cyrus Cooper, and Stefania Maggi. 2017. Association between lower limb osteoarthritis and incidence of depressive symptoms: Data from the osteoarthritis initiative. Age and Ageing 46 (3): 470\u2013476. https:\/\/doi.org\/10.1093\/ageing\/afw216.","journal-title":"Age and Ageing"},{"issue":"6","key":"1143_CR6","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/1529-0131(200106)44:6<1237::Aid-art214>3.0.Co;2-f","volume":"44","author":"JP Pelletier","year":"2001","unstructured":"Pelletier, J.P., J. Martel-Pelletier, and S.B. Abramson. 2001. Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targets. Arthritis and Rheumatism 44 (6): 1237\u20131247. https:\/\/doi.org\/10.1002\/1529-0131(200106)44:6<1237::Aid-art214>3.0.Co;2-f.","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"1143_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","volume":"7","author":"M Kapoor","year":"2011","unstructured":"Kapoor, M., J. Martel-Pelletier, D. Lajeunesse, J.P. Pelletier, and H. Fahmi. 2011. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nature Reviews Rheumatology 7 (1): 33\u201342. https:\/\/doi.org\/10.1038\/nrrheum.2010.196.","journal-title":"Nature Reviews Rheumatology"},{"issue":"3","key":"1143_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.joca.2017.10.008","volume":"26","author":"CT Appleton","year":"2018","unstructured":"Appleton, C.T. 2018. Osteoarthritis year in review 2017: Biology. Osteoarthritis and Cartilage 26 (3): 296\u2013303. https:\/\/doi.org\/10.1016\/j.joca.2017.10.008.","journal-title":"Osteoarthritis and Cartilage"},{"issue":"3","key":"1143_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/bor.0000000000000162","volume":"27","author":"CJ Malemud","year":"2015","unstructured":"Malemud, C.J. 2015. Biologic basis of osteoarthritis: State of the evidence. Current Opinion in Rheumatology 27 (3): 289\u2013294. https:\/\/doi.org\/10.1097\/bor.0000000000000162.","journal-title":"Current Opinion in Rheumatology"},{"issue":"4","key":"1143_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10195-017-0473-8","volume":"18","author":"SB Panina","year":"2017","unstructured":"Panina, Svetlana B., Igor V. Krolevets, Natalia P. Milyutina, Alexander B. Sagakyants, Igor V. Kornienko, Anzhelika A. Ananyan, Mikhail A. Zabrodin, Andrey A. Plotnikov, and Valeriy V. Vnukov. 2017. Circulating levels of proinflammatory mediators as potential biomarkers of post-traumatic knee osteoarthritis development. Journal of Orthopaedics and Traumatology 18 (4): 349\u2013357. https:\/\/doi.org\/10.1007\/s10195-017-0473-8.","journal-title":"Journal of Orthopaedics and Traumatology"},{"issue":"5","key":"1143_CR11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/art.21813","volume":"54","author":"RF Loeser","year":"2006","unstructured":"Loeser, R.F. 2006. Molecular mechanisms of cartilage destruction: Mechanics, inflammatory mediators, and aging collide. Arthritis and Rheumatism 54 (5): 1357\u20131360. https:\/\/doi.org\/10.1002\/art.21813.","journal-title":"Arthritis and Rheumatism"},{"issue":"6 Suppl 1","key":"1143_CR12","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.pmrj.2011.05.009","volume":"3","author":"MB Mueller","year":"2011","unstructured":"Mueller, M.B., and R.S. Tuan. 2011. Anabolic\/catabolic balance in pathogenesis of osteoarthritis: Identifying molecular targets. PM & R : The Journal of Injury, Function, and Rehabilitation 3 (6 Suppl 1): S3\u2013S11. https:\/\/doi.org\/10.1016\/j.pmrj.2011.05.009.","journal-title":"PM & R : The Journal of Injury, Function, and Rehabilitation"},{"key":"1143_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1248\/yakushi1947.85.4_335","volume":"85","author":"H Furukawa","year":"1965","unstructured":"Furukawa, H. 1965. On the alkaloids of Nelumbo Nucifera Gaertn. IX. Alkaloids of loti embryo. (2). Structure of neferine, a new biscoclaurine alkaloid. Yakugaku Zasshi 85: 335\u2013338.","journal-title":"Yakugaku Zasshi"},{"issue":"6","key":"1143_CR14","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1142\/S0192415X18500660","volume":"46","author":"X Wu","year":"2018","unstructured":"Wu, X., Y. Guo, X. Min, L. Pei, and X. Chen. 2018. Neferine, a bisbenzylisoquinoline alkaloid, ameliorates dextran sulfate sodium-induced ulcerative colitis. The American Journal of Chinese Medicine 46 (6): 1263\u20131279. https:\/\/doi.org\/10.1142\/S0192415X18500660.","journal-title":"The American Journal of Chinese Medicine"},{"issue":"3","key":"1143_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/bph.14537","volume":"176","author":"C Wu","year":"2019","unstructured":"Wu, C., J. Chen, R. Yang, F. Duan, S. Li, and X. Chen. 2019. Mitochondrial protective effect of neferine through the modulation of nuclear factor erythroid 2-related factor 2 signalling in ischaemic stroke. British Journal of Pharmacology 176 (3): 400\u2013415. https:\/\/doi.org\/10.1111\/bph.14537.","journal-title":"British Journal of Pharmacology"},{"key":"1143_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00011-019-01256-6","volume":"68","author":"YS Tang","year":"2019","unstructured":"Tang, Y.S., Y.H. Zhao, Y. Zhong, X.Z. Li, J.X. Pu, Y.C. Luo, and Q.L. Zhou. 2019. Neferine inhibits LPS-ATP-induced endothelial cell pyroptosis via regulation of ROS\/NLRP3\/Caspase-1 signaling pathway. Inflammation Research 68: 727\u2013738. https:\/\/doi.org\/10.1007\/s00011-019-01256-6.","journal-title":"Inflammation Research"},{"key":"1143_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fphar.2017.00238","volume":"8","author":"O Kadioglu","year":"2017","unstructured":"Kadioglu, O., B.Y.K. Law, S.W.F. Mok, S.W. Xu, T. Efferth, and V.K.W. Wong. 2017. Mode of action analyses of neferine, a bisbenzylisoquinoline alkaloid of Lotus (Nelumbo nucifera) against multidrug-resistant tumor cells. Frontiers in Pharmacology 8: 238. https:\/\/doi.org\/10.3389\/fphar.2017.00238.","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"1143_CR18","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.3390\/molecules20033496","volume":"20","author":"VK Wong","year":"2015","unstructured":"Wong, V.K., A.G. Wu, J.R. Wang, L. Liu, and B.Y. Law. 2015. Neferine attenuates the protein level and toxicity of mutant huntingtin in PC-12 cells via induction of autophagy. Molecules 20 (3): 3496\u20133514. https:\/\/doi.org\/10.3390\/molecules20033496.","journal-title":"Molecules"},{"key":"1143_CR19","doi-asserted-by":"publisher","unstructured":"Pham, D.C., Y.C. Chang, S.R. Lin, Y.M. Fuh, M.J. Tsai, and C.F. Weng. 2018. FAK and S6K1 inhibitor, neferine, dually induces autophagy and apoptosis in human neuroblastoma cells. Molecules 23 (12). https:\/\/doi.org\/10.3390\/molecules23123110.","DOI":"10.3390\/molecules23123110"},{"issue":"1","key":"1143_CR20","doi-asserted-by":"publisher","first-page":"12283","DOI":"10.1038\/s41598-017-12060-9","volume":"7","author":"LB Priya","year":"2017","unstructured":"Priya, L.B., R. Baskaran, C.Y. Huang, and V.V. Padma. 2017. Neferine ameliorates cardiomyoblast apoptosis induced by doxorubicin: Possible role in modulating NADPH oxidase\/ROS-mediated NFkappaB redox signaling cascade. Scientific Reports 7 (1): 12283. https:\/\/doi.org\/10.1038\/s41598-017-12060-9.","journal-title":"Scientific Reports"},{"key":"1143_CR21","doi-asserted-by":"publisher","unstructured":"Chen, S., B. Chu, Y. Chen, X. Cheng, D. Guo, L. Chen, J. Wang, Z. Li, Z. Hong, and D. Hong. 2019. Neferine suppresses osteoclast differentiation through suppressing NF-kappaB signal pathway but not MAPKs and promote osteogenesis. Journal of Cellular Physiology. https:\/\/doi.org\/10.1002\/jcp.28857.","DOI":"10.1002\/jcp.28857"},{"issue":"8","key":"1143_CR22","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/annrheumdis-2018-213089","volume":"77","author":"M Dubreuil","year":"2018","unstructured":"Dubreuil, Maureen, Qiong Louie-Gao, Christine E. Peloquin, Hyon K. Choi, Yuqing Zhang, and Tuhina Neogi. 2018. Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis. Annals of the Rheumatic Diseases 77 (8): 1137\u20131143. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213089.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1143_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40266-019-00660-1","volume":"36","author":"C Cooper","year":"2019","unstructured":"Cooper, Cyrus, Roland Chapurlat, Nasser Al-Daghri, Gabriel Herrero-Beaumont, Olivier Bruyere, Francois Rannou, Roland Roth, Daniel Uebelhart, and Jean-Yves Reginster. 2019. Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: What does the literature say? Drugs & Aging 36: 15\u201324. https:\/\/doi.org\/10.1007\/s40266-019-00660-1.","journal-title":"Drugs & Aging"},{"key":"1143_CR24","doi-asserted-by":"publisher","unstructured":"Lu, W., J. Shi, J. Zhang, Z. Lv, F. Guo, H. Huang, W. Zhu, and A. Chen. 2016. CXCL12\/CXCR4 axis regulates aggrecanase activation and cartilage degradation in a post-traumatic osteoarthritis rat model. International Journal of Molecular Sciences 17 (10). https:\/\/doi.org\/10.3390\/ijms17101522.","DOI":"10.3390\/ijms17101522"},{"key":"1143_CR25","doi-asserted-by":"publisher","unstructured":"Shepard, N., and N. Mitchell. 1976. Simultaneous localization of proteoglycan by light and electron microscopy using toluidine blue OA study of epiphyseal cartilage. Journal of Histochemistry & Cytochemistry 24 (5):621\u2013629. https:\/\/doi.org\/10.1177\/24.5.132503.","DOI":"10.1177\/24.5.132503"},{"issue":"Suppl 3","key":"1143_CR26","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1016\/j.joca.2010.05.026","volume":"18","author":"N Schmitz","year":"2010","unstructured":"Schmitz, N., S. Laverty, V.B. Kraus, and T. Aigner. 2010. Basic methods in histopathology of joint tissues. Osteoarthritis and Cartilage 18 (Suppl 3): S113\u2013S116. https:\/\/doi.org\/10.1016\/j.joca.2010.05.026.","journal-title":"Osteoarthritis and Cartilage"},{"key":"1143_CR27","doi-asserted-by":"publisher","unstructured":"Huang, W., C. Cheng, W.S. Shan, Z.F. Ding, F.E. Liu, W. Lu, W. He, J.G. Xu, and Z.S. Yin. 2019. Knockdown of SGK1 alleviates the IL-1beta-induced chondrocyte anabolic and catabolic imbalance by activating FoxO1-mediated autophagy in human chondrocytes. The FEBS Journal. https:\/\/doi.org\/10.1111\/febs.15009.","DOI":"10.1111\/febs.15009"},{"issue":"4","key":"1143_CR28","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1053\/joca.2000.0399","volume":"9","author":"PK Bos","year":"2001","unstructured":"Bos, P.K., G.J. van Osch, D.A. Frenz, J.A. Verhaar, and H.L. Verwoerd-Verhoef. 2001. Growth factor expression in cartilage wound healing: Temporal and spatial immunolocalization in a rabbit auricular cartilage wound model. Osteoarthritis and Cartilage 9 (4): 382\u2013389. https:\/\/doi.org\/10.1053\/joca.2000.0399.","journal-title":"Osteoarthritis and Cartilage"},{"key":"1143_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.biopha.2018.07.161","volume":"107","author":"X Huang","year":"2018","unstructured":"Huang, X., Y. Xi, Q. Pan, Z. Mao, R. Zhang, X. Ma, and H. You. 2018. Caffeic acid protects against IL-1beta-induced inflammatory responses and cartilage degradation in articular chondrocytes. Biomedicine & Pharmacotherapy 107: 433\u2013439. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.161.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"1143_CR30","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.intimp.2018.09.018","volume":"64","author":"Z Mao","year":"2018","unstructured":"Mao, Z., P. Wang, Q. Pan, X. Huang, R. Zhang, X. Shang, X. Ma, and H. You. 2018. Pravastatin alleviates interleukin 1beta-induced cartilage degradation by restoring impaired autophagy associated with MAPK pathway inhibition. International Immunopharmacology 64: 308\u2013318. https:\/\/doi.org\/10.1016\/j.intimp.2018.09.018.","journal-title":"International Immunopharmacology"},{"issue":"1","key":"1143_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jbiosc.2018.12.010","volume":"128","author":"A Oda","year":"2019","unstructured":"Oda, Akinori, Ryota Takamiya, Rin Kaneko, Haruna Yoshida, Yuta Yanagita, Hatsumi Sekiguchi, Yoshihito Nobe, and Kazuaki Muramatsu. 2019. Utility of a rotation\/revolution-type agitator for chondrocyte isolation during preparation of engineered cartilage. Journal of Bioscience and Bioengineering 128 (1): 117\u2013122. https:\/\/doi.org\/10.1016\/j.jbiosc.2018.12.010.","journal-title":"Journal of Bioscience and Bioengineering"},{"issue":"3","key":"1143_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/s0945-053x(02)00007-0","volume":"21","author":"A Liacini","year":"2002","unstructured":"Liacini, A., J. Sylvester, W.Q. Li, and M. Zafarullah. 2002. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biology 21 (3): 251\u2013262. https:\/\/doi.org\/10.1016\/s0945-053x(02)00007-0.","journal-title":"Matrix Biology"},{"issue":"22","key":"1143_CR33","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.1073\/pnas.83.22.8749","volume":"83","author":"ER Pettipher","year":"1986","unstructured":"Pettipher, E.R., G.A. Higgs, and B. Henderson. 1986. Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proceedings of the National Academy of Sciences of the United States of America 83 (22): 8749\u20138753. https:\/\/doi.org\/10.1073\/pnas.83.22.8749.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"1143_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/joca.1998.0237","volume":"7","author":"P Needleman","year":"1999","unstructured":"Needleman, P., and P.T. Manning. 1999. Interactions between the inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) pathways: Implications for therapeutic intervention in osteoarthritis. Osteoarthritis and Cartilage 7 (4): 367\u2013370. https:\/\/doi.org\/10.1053\/joca.1998.0237.","journal-title":"Osteoarthritis and Cartilage"},{"issue":"9","key":"1143_CR35","first-page":"S342","volume":"41","author":"JP Pelletier","year":"1998","unstructured":"Pelletier, J.P., J.C. Fernandes, G. Tardif, V. Lascau-Coman, M. Dupuis, and J. Martel-Pelletier. 1998. Direct in vivo transfer of the IL-1Ra gene in osteoarthritic rabbit knee joints: Prevention of the disease progression. Arthritis and Rheumatism 41 (9): S342\u2013S342.","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"1143_CR36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/RHU.0b013e3181b1d873","volume":"15","author":"PA Simkin","year":"2009","unstructured":"Simkin, Peter A. 2009. Rethinking the physiology of articular cartilage. Journal of clinical Rheumatology 15 (5): 260\u2013263. https:\/\/doi.org\/10.1097\/RHU.0b013e3181b1d873.","journal-title":"Journal of clinical Rheumatology"},{"issue":"7033","key":"1143_CR37","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature03417","volume":"434","author":"H Stanton","year":"2005","unstructured":"Stanton, H., F.M. Rogerson, C.J. East, S.B. Golub, K.E. Lawlor, C.T. Meeker, C.B. Little, K. Last, P.J. Farmer, I.K. Campbell, A.M. Fourie, and A.J. Fosang. 2005. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434 (7033): 648\u2013652. https:\/\/doi.org\/10.1038\/nature03417.","journal-title":"Nature"},{"issue":"2","key":"1143_CR38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/art.22334","volume":"56","author":"R-H Song","year":"2007","unstructured":"Song, Ruo-Hua, Micky D. Tortorella, Anne-Marie Malfait, James T. Alston, Zhiyong Yang, Elizabeth C. Arner, and David W. Griggs. 2007. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis and Rheumatism 56 (2): 575\u2013585. https:\/\/doi.org\/10.1002\/art.22334.","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"1143_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1172\/jci10564","volume":"107","author":"LA Neuhold","year":"2001","unstructured":"Neuhold, L.A., L. Killar, W.G. Zhao, M.L.A. Sung, L. Warner, J. Kulik, J. Turner, et al. 2001. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. Journal of Clinical Investigation 107 (1): 35\u201344. https:\/\/doi.org\/10.1172\/jci10564.","journal-title":"Journal of Clinical Investigation"},{"issue":"12","key":"1143_CR40","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1002\/art.25002","volume":"60","author":"CB Little","year":"2009","unstructured":"Little, C.B., A. Barai, D. Burkhardt, S.M. Smith, A.J. Fosang, Z. Werb, M. Shah, and E.W. Thompson. 2009. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis and Rheumatism 60 (12): 3723\u20133733. https:\/\/doi.org\/10.1002\/art.25002.","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"1143_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cyto.2004.06.003","volume":"28","author":"ZY Fan","year":"2004","unstructured":"Fan, Z.Y., B. Bau, H.Q. Yang, and T. Aigner. 2004. IL-1 beta induction of IL-6 and LIF in normal articular human chondrocytes involves the ERK, p38 and NF kappa B signaling pathways. Cytokine 28 (1): 17\u201324. https:\/\/doi.org\/10.1016\/j.cyto.2004.06.003.","journal-title":"Cytokine"},{"issue":"2","key":"1143_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2174\/138945007779940115","volume":"8","author":"J Saklatvala","year":"2007","unstructured":"Saklatvala, J. 2007. Inflammatory signaling in cartilage: MAPK and NF-kappa B pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis. Current Drug Targets 8 (2): 305\u2013313. https:\/\/doi.org\/10.2174\/138945007779940115.","journal-title":"Current Drug Targets"},{"key":"1143_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bcp.2019.02.030","volume":"165","author":"G Herrero-Beaumont","year":"2019","unstructured":"Herrero-Beaumont, Gabriel, Sandra Perez-Baos, Olga Sanchez-Pernaute, Jorge A. Roman-Blas, Ana Lamuedra, and Raquel Largo. 2019. Targeting chronic innate inflammatory pathways, the main road to prevention of osteoarthritis progression. Biochemical Pharmacology 165: 24\u201332. https:\/\/doi.org\/10.1016\/j.bcp.2019.02.030.","journal-title":"Biochemical Pharmacology"},{"issue":"6","key":"1143_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41434-019-0068-5","volume":"26","author":"D-W Yang","year":"2019","unstructured":"Yang, Da-Wei, Gui-Bin Qian, Ming-Jiu Jiang, Peng Wang, and Kun-Zheng Wang. 2019. Inhibition of microRNA-495 suppresses chondrocyte apoptosis through activation of the NF-kappaB signaling pathway by regulating CCL4 in osteoarthritis. Gene Therapy 26 (6): 217\u2013229. https:\/\/doi.org\/10.1038\/s41434-019-0068-5.","journal-title":"Gene Therapy"},{"issue":"Suppl 2","key":"1143_CR45","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/s1063-4584(08)60008-4","volume":"16","author":"SB Abramson","year":"2008","unstructured":"Abramson, S.B. 2008. Osteoarthritis and nitric oxide. Osteoarthritis and Cartilage 16 (Suppl 2): S15\u2013S20. https:\/\/doi.org\/10.1016\/s1063-4584(08)60008-4.","journal-title":"Osteoarthritis and Cartilage"},{"issue":"4","key":"1143_CR46","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1063-4584(02)00354-0","volume":"11","author":"JF Schaefer","year":"2003","unstructured":"Schaefer, J.F., M.L. Millham, B. de Crombrugghe, and L. Buckbinder. 2003. FGF signaling antagonizes cytokine-mediated repression of Sox9 in SW1353 chondrosarcoma cells. Osteoarthritis and Cartilage 11 (4): 233\u2013241.","journal-title":"Osteoarthritis and Cartilage"},{"issue":"8","key":"1143_CR47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.joca.2005.04.004","volume":"13","author":"M Gebauer","year":"2005","unstructured":"Gebauer, M., J. Saas, F. Sohler, J. Haag, S. Soder, M. Pieper, E. Bartnik, J. Beninga, R. Zimmer, and T. Aigner. 2005. Comparison of the chondrosarcoma cell line SW1353 with primary human adult articular chondrocytes with regard to their gene expression profile and reactivity to IL-1beta. Osteoarthritis and Cartilage 13 (8): 697\u2013708. https:\/\/doi.org\/10.1016\/j.joca.2005.04.004.","journal-title":"Osteoarthritis and Cartilage"}],"updated-by":[{"DOI":"10.1007\/s10753-022-01760-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000}}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-01143-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-019-01143-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-01143-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T22:07:42Z","timestamp":1666217262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-019-01143-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1143"],"URL":"https:\/\/doi.org\/10.1007\/s10753-019-01143-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10753-022-01760-8","asserted-by":"object"}]},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"2 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10753-022-01760-8","URL":"https:\/\/doi.org\/10.1007\/s10753-022-01760-8","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}